Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles.
about
Altering the tropism of lentiviral vectors through pseudotyping.A novel mammalian expression system derived from components coordinating nicotine degradation in arthrobacter nicotinovorans pAO1.Improved tagging strategy for protein identification in mammalian cellsTargeted infection of HIV-1 Env expressing cells by HIV(CD4/CXCR4) vectors reveals a potential new rationale for HIV-1 mediated down-modulation of CD4Manufacture of tumor- and virus-specific T lymphocytes for adoptive cell therapiesLentiviral vectors to probe and manipulate the Wnt signaling pathwayA hydrophobic binding surface on the human immunodeficiency virus type 1 Nef core is critical for association with p21-activated kinase 2.A third-generation lentivirus vector with a conditional packaging systemThe effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines.Development of an avian leukosis-sarcoma virus subgroup A pseudotyped lentiviral vectorNovel bovine lentiviral vectors based on Jembrana disease virus.Identification of a novel proliferation-inducing determinant using lentiviral expression cloning.Rab11-FIP1C and Rab14 direct plasma membrane sorting and particle incorporation of the HIV-1 envelope glycoprotein complex.Simplified production and concentration of HIV-1-based lentiviral vectors using HYPERFlask vessels and anion exchange membrane chromatography.The HIV envelope but not VSV glycoprotein is capable of mediating HIV latent infection of resting CD4 T cellsCD40 ligand (CD154) incorporated into HIV virions induces activation-induced cytidine deaminase (AID) expression in human B lymphocytes.Efficient transduction by an amphotropic retrovirus vector is dependent on high-level expression of the cell surface virus receptorDevelopment of a self-inactivating lentivirus vector.High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells.Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cellsCleavage of the murine leukemia virus transmembrane env protein by human immunodeficiency virus type 1 protease: transdominant inhibition by matrix mutations.Development of multigene and regulated lentivirus vectors.Marking and gene expression by a lentivirus vector in transplanted human and nonhuman primate CD34(+) cellsMinimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors.Cocal-pseudotyped lentiviral vectors resist inactivation by human serum and efficiently transduce primate hematopoietic repopulating cells.The carboxy-terminal fragment of nucleolin interacts with the nucleocapsid domain of retroviral gag proteins and inhibits virion assembly.Entry kinetics and cell-cell transmission of surface-bound retroviral vector particles.Lentivirus vector-mediated hematopoietic stem cell gene transfer of common gamma-chain cytokine receptor in rhesus macaques.Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant RevDesign of an HIV-1 lentiviral-based gene-trap vector to detect developmentally regulated genes in mammalian cells.Transduction of human NOD/SCID-repopulating cells with both lymphoid and myeloid potential by foamy virus vectors.Current status of viral gene therapy for brain tumours.In vivo assessment of gene delivery to keratinocytes by lentiviral vectorsAdvanced modular self-inactivating lentiviral expression vectors for multigene interventions in mammalian cells and in vivo transduction.Transduction of interphase cells by avian sarcoma virus.Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases.Optimized lentiviral transduction of mouse bone marrow-derived mesenchymal stem cellsHuman immunodeficiency virus type 1 protease inhibitor drug-resistant mutants give discordant results when compared in single-cycle and multiple-cycle fitness assays.Production, purification and titration of a lentivirus-based vector for gene delivery purposes.Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant.
P2860
Q24538987-FDBB633F-3AF9-4DBF-BCC2-ADEDFF075CDEQ24816289-060862AB-92B4-4D3E-A2E2-F2DCBEF81630Q24816978-48C51328-CC24-4293-8868-F056C215DBC4Q25257643-E9DA090D-E402-4FAA-9E8A-4F0968CE3A96Q28085769-689B13AD-9524-49D1-84AE-F33A9456295DQ28472995-BBD3258B-A950-4550-9E1B-9B1CE2250DE5Q28768294-5088A0D6-F22A-4336-AAEB-44BBCC36FA35Q29616120-40710902-C499-4207-925F-4B1ECD5D6F11Q30452571-55590AA3-770E-4E19-ABD3-2D62614C104DQ30453447-C5140AC4-45D8-42C8-B3B7-8AC24E5533F3Q30885539-B2993E3B-BD8E-48B6-8A38-8FE26348773BQ30979937-8398352D-146C-47C1-BFCD-0C2544D58F22Q31115300-3364F48C-B605-44C7-A8D5-625472051A15Q33409769-AA3E6B41-D020-4CA3-B2EE-907DEA2E8EDCQ33511958-62658DE1-2EF7-4919-A0C6-F0CA075652DBQ33631142-7148C8AD-5CAA-4846-A700-D99067370A1AQ33639579-32E84807-82FE-4CE9-84B9-6D0900825086Q33784841-0ECBA935-646B-475B-A95D-5148DF610CE0Q33785302-678CCAEC-38B7-4FE2-9320-056B100D017FQ33785609-D4AFA6DC-5E0E-4E57-B1B7-3617E9FEE16BQ33785977-15B46656-EB23-44A9-8438-223162E761DCQ33787285-269C19B7-E1D2-41C4-A597-796E912ED824Q33793274-F3E5DA6B-BF5F-44EB-9BB8-6AF2081F74F2Q33814215-C394FB5D-E96B-4137-BAA5-6ECB4D1905AAQ33822226-4F2B4F5B-836B-4EDC-8A49-47C6928EA984Q33826575-49A31249-05EE-4F3B-BE26-99E44488063EQ33831103-722D7F92-56AA-4190-A32D-ED8743ADBC36Q33851061-1AE415ED-BA11-456D-81EF-533AE47D3719Q33851112-B91193AA-999A-4348-A348-3D529A53AE64Q34019566-6D7CE641-3C33-4000-A0B7-88184669F0E7Q34032399-B1E52911-08BE-41E6-A671-DC099DD9111FQ34074791-F1ED2037-0E00-493D-A9B2-8A044C535066Q34328596-6996C451-3A40-497B-87AE-0AC44A578276Q34329754-7CF79E12-8CF1-4A59-A93B-1D7B8BCC598BQ34364782-561C2AB4-6F90-41FB-8E9E-094083F4A263Q34367266-C8C0BD2C-4205-40D6-959B-54BA18F3EC04Q34378615-AB9C3463-8E83-4154-B188-7D6CD84A4CC0Q34489422-3B937E42-A8F1-405F-84E7-90FB36A228DEQ34534697-2A6E41FA-8229-4471-BF7E-018C0B9ECA6EQ34563731-4244C3FF-AFB3-4C1B-BCE3-1997877D7471
P2860
Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Transduction of nondividing ce ...... gh-titer HIV type 1 particles.
@en
Transduction of nondividing ce ...... gh-titer HIV type 1 particles.
@nl
type
label
Transduction of nondividing ce ...... gh-titer HIV type 1 particles.
@en
Transduction of nondividing ce ...... gh-titer HIV type 1 particles.
@nl
prefLabel
Transduction of nondividing ce ...... gh-titer HIV type 1 particles.
@en
Transduction of nondividing ce ...... gh-titer HIV type 1 particles.
@nl
P2093
P2860
P356
P1476
Transduction of nondividing ce ...... gh-titer HIV type 1 particles.
@en
P2093
Harmison G
Karlsson S
Kluepfel-Stahl S
Schubert M
P2860
P304
15266-15271
P356
10.1073/PNAS.93.26.15266
P407
P577
1996-12-01T00:00:00Z